Bristol-Myers Squibb opened its new biologics discovery center

| By | Bristol-Myers Squibb, Cancer Drugs, Drug Development

Bristol-Myers Squibb, a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines, officially opened the newest building to its Redwood City (California, USA) research and development campus in Woodside Technology Park.

The newly-opened site serves as Bristol-Myers Squibb’s biologics discovery center, focusing primarily on cancer immunotherapies – drugs that manipulate the immune system so that the body’s own defensive network recognizes and attacks tumors. Global design firm Stantec provided architecture, interior design, lab planning, and complete engineering.

The new lab and office space houses a state-of-the-art research facility, complete with well thought-out research and material flows, security controls, collaboration spaces, safety considerations and interactive lab and office arrangements. The expansion adds a third building – housing just over 300 employees – to Bristol-Myers Squibb’s Bay Area hub for discovering pioneering cancer therapies. The building’s design features dramatic entry spaces, vibrant and inviting social and collaborative areas, light-filled workspaces that showcase open-plan offices, and an outdoor patio that serves as a communal campus gathering space.

The new Redwood City facility is designed to set a new standard in energy and water efficiency. The Redwood City office is the first Bristol-Myers Squibb site to undertake the “Energy Star Challenge for Industry”—a program that requires a 10 percent reduction in energy usage over the next five years.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.